| Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography P Page Jama 295 (2), 172-179, 2006 | 1320 | 2006 |
| Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity T Lisman, TN Bongers, J Adelmeijer, HLA Janssen, MPM de Maat, ... Hepatology 44 (1), 53-61, 2006 | 584 | 2006 |
| Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma JC Chambers, W Zhang, J Sehmi, X Li, MN Wass, P Van der Harst, ... Nature genetics 43 (11), 1131-1138, 2011 | 529 | 2011 |
| EASL Clinical Practice Guidelines: Vascular diseases of the liver European Association For The Study Of The Liver Journal of hepatology 64 (1), 179-202, 2016 | 489 | 2016 |
| Coagulation disorders after traumatic brain injury BS Harhangi, EJO Kompanje, FWG Leebeek, AIR Maas Acta neurochirurgica 150 (2), 165-175, 2008 | 449 | 2008 |
| Etiology, management, and outcome of the Budd-Chiari syndrome S Darwish Murad, A Plessier, M Hernandez-Guerra, FM Fabris, CE Eapen, ... Annals of internal medicine 151 (3), 167-175, 2009 | 437 | 2009 |
| Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study M Kavousi, S Elias-Smale, JHW Rutten, MJG Leening, R Vliegenthart, ... Annals of internal medicine 156 (6), 438-444, 2012 | 403 | 2012 |
| Von Willebrand’s disease FWG Leebeek, JCJ Eikenboom New England Journal of Medicine 375 (21), 2067-2080, 2016 | 388 | 2016 |
| Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome … NL Smith, MH Chen, A Dehghan, DP Strachan, S Basu, N Soranzo, ... Circulation 121 (12), 1382-1392, 2010 | 360 | 2010 |
| Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis JH Smalberg, LR Arends, DC Valla, JJ Kiladjian, HLA Janssen, ... Blood, The Journal of the American Society of Hematology 120 (25), 4921-4928, 2012 | 354 | 2012 |
| Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis T Lisman, FWG Leebeek, LO Mosnier, BN Bouma, JCM Meijers, ... Gastroenterology 121 (1), 131-139, 2001 | 319 | 2001 |
| Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study EM Koehler, EPC Plompen, JNL Schouten, BE Hansen, S Darwish Murad, ... Hepatology 63 (1), 138-147, 2016 | 275 | 2016 |
| High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability TN Bongers, MPM de Maat, MLPJ van Goor, V Bhagwanbali, ... Stroke 37 (11), 2672-2677, 2006 | 266 | 2006 |
| Haemostatic abnormalities in patients with liver disease T Lisman, FWG Leebeek, PG de Groot Journal of hepatology 37 (2), 280-287, 2002 | 262 | 2002 |
| Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B W Miesbach, K Meijer, M Coppens, P Kampmann, R Klamroth, ... Blood, The Journal of the American Society of Hematology 131 (9), 1022-1031, 2018 | 224 | 2018 |
| The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study M Nijkeuter, M Söhne, LW Tick, PW Kamphuisen, MHH Kramer, ... Chest 131 (2), 517-523, 2007 | 221 | 2007 |
| Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ... Blood, The Journal of the American Society of Hematology 122 (11), 1954-1962, 2013 | 219 | 2013 |
| Etiology, management, and outcome of the Budd-Chiari syndrome SD Murad, A Plessier, M Hernandez-Guerra, F Fabris, CE Eapen, ... Annals of internal medicine 151 (3), 167-175, 2009 | 211 | 2009 |
| Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment T Lisman, FWG Leebeek Digestive surgery 24 (4), 250-258, 2007 | 206 | 2007 |
| Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery RJ Porte, FWG Leebeek Drugs 62 (15), 2193-2211, 2002 | 191 | 2002 |
